Termination of Direct License to Salix. In the event that the sublicense granted by Progenics to Salix under the Progenics-Salix Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by Salix, then the license granted by the University to Salix under Section 5.2.1 hereof shall likewise be automatically terminated to the same extent.
Appears in 2 contracts
Samples: Agreement (Salix Pharmaceuticals LTD), 2010 Agreement (Progenics Pharmaceuticals Inc)
Termination of Direct License to Salix. In If and to the event extent that the sublicense license granted by Progenics to Salix under the Progenics-Salix this Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by SalixProgenics pursuant to Section 10.2 or 10.3, then the license granted by the University ProNev to Salix under Section 5.2.1 hereof 13.22(b) shall likewise be automatically terminated to the same extent.
Appears in 2 contracts
Samples: License Agreement (Salix Pharmaceuticals LTD), License Agreement (Progenics Pharmaceuticals Inc)
Termination of Direct License to Salix. In If and to the event extent that the sublicense license granted by Progenics to Salix under the Progenics-Salix this Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by SalixProgenics pursuant to Section 10.2 or 10.3, then the license granted by the University Excelsior to Salix under Section 5.2.1 hereof 13.23(b) shall likewise be automatically terminated to the same extent.
Appears in 1 contract
Termination of Direct License to Salix. In If and to the event extent that the sublicense license granted by Progenics to Salix under the Progenics-Salix this Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by SalixProgenics pursuant to Section 10.2 or 10.3, then the license granted by the University Excelsior to Salix under Section 5.2.1 hereof 13.23(b) shall likewise be automatically terminated to the same extent.. [*] CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION
Appears in 1 contract